|
Match
|
Document |
Document Title |
|
|
US20090227554 |
STABLE LIQUID FORMULATIONS OF ANTI-INFECTIVE AGENTS AND ADJUSTED ANTI-INFECTIVE AGENT DOSING REGIMENS
Provided are methods of determining a resistance-adjusted dosage regimen of an anti-infective agent for treatment of an infection of a mammal by a resistant infective organism, wherein an effective...
|
|
|
US20090176755 |
PHARMACEUTICAL COMPOSITIONS COMPRISING AN ANTIBIOTIC
The present invention relates to cefdinir. More particularly to pharmaceutical formulations comprising cefdinir in a defined polymorphic form and processes for the preparation thereof. Furthermore,...
|
|
|
US20090175952 |
Cefuroxime axetil granule and process for the preparation thereof
A cefuroxime axetil granule composition comprising a non-crystalline cefuroxime axetil solid dispersion or a substantially amorphous cefuroxime axetil, sucrose fatty acid ester, methacrylic...
|
|
|
US20090143335 |
MODIFIED ABSORPTION FORMULATION OF GABOXADOL
The present invention relates to a pharmaceutical composition comprising gaboxadol or a pharmaceutically acceptable salt thereof and one or more inhibitors of PAT1 and/or one or more inhibitors of...
|
|
|
US20090131394 |
BROAD SPECTRUM BETA-LACTAMASE INHIBITORS
Broad spectrum beta-lactamase inhibitors. Certain inhibitors also exhibit potent antibiotic activity in addition to beta-lactamase inhibition. Compounds of the invention are designed such that on...
|
|
|
US20090082325 |
Cefidinir Oral Suspension
The present invention discloses a novel powder for oral suspension of cefdinir. Also disclosed are methods of preparing the suspension and methods of treatment using the suspension.
|
|
|
US20090023638 |
SPILL RESISTANT ANTIBIOTIC FORMULATIONS
The disclosure is directed to a pharmaceutical kit with a first set, a second set and a third set of components. The first set of components can be a carbomer in an aqueous vehicle, the second set...
|
|
|
US20090012054 |
Cephem Compounds and Use as Antimicrobial Agents
The present invention provides a compound of the formula [I]: wherein R1 is lower alkyl, etc. and R2 is hydrogen, etc., or R1 and R2 are bonded together to form lower alkylene; R3 is a group...
|
|
|
US20090005763 |
Implantable Devices and Methods for Delivering Drugs and Other Substances to Treat Sinusitis and Other Disorders
Implantable devices and methods for delivering drugs and other substances to locations within the body of a human or animal subject to treat or diagnose sinusitis and a variety of other disorders....
|
|
|
US20080221076 |
Crystalline Sodium Salt of Cephalosporin Antibiotic
The present invention relates to novel polymorph of Ceftiofur sodium as a crystalline product. The present invention also provides a process for the preparation of crystalline Ceftiofur sodium of...
|
|
|
US20080187594 |
Dosage Form With Improved Release Of Cefuroximaxetil
The invention relates to a pharmaceutical composition comprising cefuroximaxetil and at least one carrageenan selected from the group consisting of κ-carrageenan, λ-carrageenan and...
|
|
|
US20080176825 |
Oral Neurotherapeutic Cefazolin Compositons
The treatment of neurological disorders using cefazolin compositions and pharmaceutical compositions including oral dosage forms that include cefazolin compositions are described.
|
|
|
US20080103121 |
CEPHALOSPORIN DERIVATIVE FORMULATION
The present invention relates to a freeze-dried formulation for cephalosporin derivatives having increased stability and a method for preparing such a formulation using certain excipients for...
|
|
|
US20080096858 |
Method of Stabilizing Disordered Cefovecin Sodium Salt
A method of stabilizing pharmaceutical compositions containing cefovecin sodium salt which is in an amorphous or other disordered state is disclosed.
|
|
|
US20080069879 |
STABLE SOLID DOSAGE FORM CONTAINING AMORPHOUS CEFDITOREN PIVOXIL AND PROCESS FOR PREPARATION THEREOF
The present invention relates to stable solid dosage form and a dry process for preparing amorphous cefditoren pivoxil solid dosage forms and coating the solid dosage form with one or more layers...
|
|
|
US20080069850 |
Multicomponent bioactive intravaginal ring
Intravaginal ring devices have multicomponent drug releasing substrates loaded with at least one bioactive agent and designed to effect contraception and/or provide means to treat and/or prevent...
|
|
|
US20080032962 |
Stabilized Freeze-Dried Formulation for Cephalosporin Derivatives
The present invention relates to a freeze-dried formulation for cephalosporin derivatives having increased stability, a solution for obtaining and a method for preparing such a formulation, as well...
|